2016 Hematological Malignancies
BV: Increased Pulmonary Toxicity Phase I Combination of BV and ABVD
ABVD with Brentuximab vedotin N=25
AVD with Brentuximab vedotin N=26
Preferred term
Any event
11 (44) 9 (36)
0 0 0 0
Pulmonary toxicity
Interstitial lung disease
1 (4) 1 (4)
Pneumonitis
Ansell S et al. presented at ASH 2012, San Diego, USA
Made with FlippingBook